Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment by Toshiki Terao, Yosuke Minami

Get full text

An HSP90 Inhibitor Overcomes FLT3 Inhibitor Resistance in FLT3/ITD-Positive Leukemia Cells with an N676K Mutation by Hiraku Ogata, Yosuke Minami

Get full text

Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein by Haruka Shinohara, Yosuke Minami, Tomoki Naoe, Yukihiro Akao

Get full text

Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia by Motoki Eguchi, Yosuke Minami, Ayumi Kuzume, SungGi Chi

Get full text

Emergence of Natural Killer Cell Large Granular Lymphocytes during Gilteritinib Treatment in Acute Myeloid Leukemia with FLT3-ITD Mutation by Shintaro Izumi, Yosuke Minami, Shinichi Masuda, Yoshikazu Utsu, Emiko Sakaida, Nobuyuki Aotsuka

Get full text

Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reports by Junichiro Yuda, Nobuhiko Yamauchi, Ayumi Kuzume, Yong-Mei Guo, Nobue Sato, Yosuke Minami

Get full text

Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia by Hironori Arai, Yosuke Minami, SungGi Chi, Yoshikazu Utsu, Shinichi Masuda, Nobuyuki Aotsuka

Get full text

Pre-operative Serum Albumin Predicts Native Liver Survival in Biliary Atresia by Kakeru Machino, Kotaro Mimori, Seiya Ogata, Yosuke Minami, Hirofumi Shimizu, Michitoshi Yamashita, Hideaki Tanaka

Get full text

Advancements in minimal residual disease detection: a practical approach using single-cell droplet PCR for comprehensive monitoring in hematological malignancy by Satoshi Uchiyama, Kentaro Fukushima, Seiichiro Katagiri, Junichi Tsuchiya, Tomohiro Kubo, SungGi Chi, Yosuke Minami

Get full text

Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in mice. by Kiyoko Yamamoto, Shinobu Tsuzuki, Yosuke Minami, Yukiya Yamamoto, Akihiro Abe, Koichi Ohshima, Masao Seto, Tomoki Naoe

Get full text

P665: RAPID AND DEEP RESPONSES WITH ASCIMINIB IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS (TKIS) IN THE PHAS... by Timothy Hughes, Delphine Rea, Carla Boquimpani, Yosuke Minami, Michael Mauro, Jorge Cortes, Jane Apperley, Valentin Garcia Gutierrez, Shruti Kapoor, Meryem Ktiouet-Dawson, Vishal Dhamal, Andreas Hochhaus

Get full text

Richter transformation acquiring PLCG2 mutation during Bruton tyrosine kinase inhibitors treatment by Takafumi Tsushima, Nobue Sato, Yong‐Mei Guo, Hirotaka Nakamura, Kodai Kunisada, Song‐Gi Chi, Kenta Akie, Yuki Takahashi, Saki Nakamura, Kaoru Shimada, Genichiro Ishii, Yosuke Minami, Junichiro Yuda

Get full text

Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study by Junichiro Yuda, Noriko Doki, Hiroshi Matsuoka, Takafumi Yokota, Akihiro Tomita, Naoto Takahashi, Itaru Matsumura, Kohmei Kubo, Tatsunori Goto, Keita Kirito, Akio Maki, Makoto Aoki, Alex Allepuz, Yosuke Minami

Get full text

S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL by Elias Jabbour, Hagop Kantarjian, Ibrahim Aldoss, Pau Montesinos, Jessica Leonard, David Gomez, Maria Baer, Carlo Gambacorti-Passerini, James Mccloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice Wang, Meliessa Hennessy, Niti Patel, Alexander Vorog, Bingxia Wang, Huilan Yao, Tammie Yeh, Josep Maria Ribera

Get full text